ACTSI Investigator Dr. R. Donald Harvey in the News

R. Donald Harvey, PharmD, FCCP, BCOP, ACTSI investigator, Assistant Professor, Hematology and Medical Oncology Emory School of Medicine and Winship Cancer Institute's director of the Phase I Clinical Trials Section

WAGA TV | Possible $44 billion cuts in prescription drugs
January 23, 2015

Winship Cancer Magazine | Stepping up for Science
Fall 2014

Emory News Center | Phase I trials: Where all anticancer drugs begin
April 1, 2014

Emory News Center | Roots Compound Could Help Fight Breast Cancer Metastasis
May 25, 2011

ACTSI CRN Clinical Research Site: Winship Cancer Institute Developmental Therapeutics Unit 0;(DTU)